Cold Genesys

Cold Genesys is a California-based clinical stage biotech company focusing on an immunotherapy treatment for bladder cancer. They are utilizing an oncolytic adenovirus construct which both directly attacks tumor cells and activates the immune response to cancer cells. The company’s main product CG0070 is undergoing a pivotal Phase III trial with the promise to offer the first new standard for bladder cancer treatment since the 1990s.

Learn more: http://www.coldgenesys.com/